Sumitomo Chemical Intrinsic Value
Sumitomo Chemical (SUMICHEM) median intrinsic value is ₹156.14 from 10 valuation models (range ₹104–₹260), vs current price ₹520.45 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit Sumitomo Chemical screener.
SUMICHEM Valuation Methods Summary — DCF, Graham Number & P/E
Sumitomo Chemical intrinsic value across 10 models vs current price ₹520.45 — upside/downside and value range per method. Read SUMICHEM ex-dividend dates for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹156.14 | ₹124.91 - ₹187.37 | -70.0% | EPS: ₹8.92, Sector P/E: 12x |
| Book Value Method | asset | ₹104.09 | ₹93.68 - ₹114.50 | -80.0% | Book Value/Share: ₹68.02, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹156.14 | ₹140.53 - ₹171.75 | -70.0% | Revenue/Share: ₹57.39, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹208.18 | ₹187.36 - ₹229.00 | -60.0% | EBITDA: ₹664.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹208.18 | ₹166.54 - ₹249.82 | -60.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹156.14 | ₹140.53 - ₹171.75 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹156.14 | ₹140.53 - ₹171.75 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹260.23 | ₹234.21 - ₹286.25 | -50.0% | ROE: 13.1%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹156.14 | ₹140.53 - ₹171.75 | -70.0% | EPS: ₹8.92, BVPS: ₹68.02 |
| Dividend Yield Method | dividend | ₹156.14 | ₹140.53 - ₹171.75 | -70.0% | DPS: ₹1.30, Target Yield: 3.5% |
SUMICHEM Intrinsic Value vs Market Price — All Valuation Models
Sumitomo Chemical fair value range ₹104–₹260 vs current market price ₹520.45 across 10 valuation models. Analyse Sumitomo Chemical ownership pattern to track promoter, FII and institutional holdings.
SUMICHEM Intrinsic Value Analysis — Undervalued or Overvalued?
Sumitomo Chemical median intrinsic value ₹156.14, current price ₹520.45 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of SUMICHEM?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Sumitomo Chemical (SUMICHEM) is ₹156.14 (median value). With the current market price of ₹520.45, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹104.09 to ₹260.23, indicating ₹104.09 - ₹260.23.
Is SUMICHEM undervalued or overvalued?
Based on our multi-method analysis, Sumitomo Chemical (SUMICHEM) appears to be trading above calculated value by approximately 70.0%.
SUMICHEM Financial Health — Key Ratios vs Industry Benchmarks
Sumitomo Chemical financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 30.09 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 13.1% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 20.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.64x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
SUMICHEM Cash Flow Quality — Operating & Free Cash Flow
Sumitomo Chemical operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹446 Cr | ₹280 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹452 Cr | ₹256 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹757 Cr | ₹547 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹389 Cr | ₹226 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹222 Cr | ₹77 Cr | Positive Free Cash Flow | 7/10 |